Summary
Very low density lipoprotein receptor (VLDLR) is thought to participate in the pathogenesis of atherosclerosis induced by VLDL and β-VLDL. The present study was undertaken to elucidate the effects of VLDL and β-VLDL on VLDLR expression and its signaling pathway. RAW264.7 cells were incubated with VLDL and β-VLDL. The expression of VLDLR mRNA was detected by RT-PCR. The transcriptional activity of VLDLR gene was detected in recombinant plasmid pGL4.2VR-luciferase transfected RAW264.7. Western blot assay was used to detect the changes of phosphorylated ERK1/2 protein. Inhibitors or activators were used to observe the signal pathway involving VLDLR expression regulation. The results showed that VLDL and β-VLDL stimulated ERK1/2 activity in a PKC-dependent manner. VLDL or β-VLDL-induced VLDLR expression on macrophages was extremely abolished by inhibitors ERK1/2 or PKC. Our findings revealed that VLDL or β-VLDL-induced VLDLR expression via PKC/ERK cascades and the effect was linked to the transcriptional activation of VLDLR gene promoter.
Similar content being viewed by others
References
MacDougall ED, Kramer F, Polinsky P, et al. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice. Am J Pathol, 2006, 168(6):2064–2073
Hiltunen TP, Luoma JS, Nikkari T, et al. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation, 1998, 97(11):1079–1086
Qu S, Wu F, Tian J, et al. Role of VLDL receptor in the process of foam cell formation. J Huazhong Univ Sci Technol Med Sci, 2004, 24(1):1–4, 8
Tiebel O, Oka K, Robinson K, et al. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis, 1999, 145(2):239–251
Nakazato K, Ishibashi T, Nagata K, et al. Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia. Atherosclerosis, 2001, 155(2):439–444
Eck MV, Oost J, Goudriaan JR, et al. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis, 2005, 183(2):230–237
Gouni-Berthold I, Berthold HK, Seul C, et al. Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth. Br J Pharmacol, 2001, 132(8):1725–1734
Kawakami A, Tanaka A, Chiba T, et al. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation, 2003, 108(21):2679–2688
Hoe HS, Rebeck GW. Regulation of ApoE receptor proteolysis by ligand binding. Brain Res Mol Brain Res, 2005, 137(1–2):31–39
Zhao D, Letterman J, Schreiber BM. Beta-Migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on beta VLDL plus EGF-induced cell proliferation. J Biol Chem, 2001, 276(33):30579–33088
Sachinidis A, Kettenhofen R, Seewald S, et al. Evidence that lipoproteins are carriers of bioactive factors. Arterioscler Thromb Vasc Biol, 1999, 19(10):2412–2421
Pedreno J, Hurt-Camejo E, Wiklund O, et al. Low-density lipoprotein (LDL) binds to a G-protein coupled receptor in human platelets. Evidence that the proaggregatory effect induced by LDL is modulated by down-regulation of binding sites and desensitization of its mediated signaling. Atherosclerosis, 2001, 155(1):99–112
Banfi C, Mussoni L, Ris P, et al. Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells. Circ Res, 1999, 85(2):208–217
Webb DJ, Thomas KS, Gonias SL. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth. J Cell Biol, 2001, 152(4):741–752
Webb DJ, Nguyen DH, Sankovic M, et al. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem, 1999, 274(11):7412–7420
Strasser V, Fasching D, Hauser C, et al. Receptor clustering is involved in Reelin signaling. Mol Cell Biol, 2004, 24(3):1378–1386
Bock HH, Jossin Y, May P, et al. Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1. J Biol Chem, 2004, 279(32):33 471–33 479
Shirotani-Ikejima H, Kokame K, Hamuro T, et al. Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs. Biochem Biophys Res Commun, 2002, 299(5):847–852
Kreuter R, Soutar AK, Wade DP. Transcription factors CCAAT/enhancer-binding protein beta and nuclear factor-Y bind to discrete regulatory elements in the very low density lipoprotein receptor promoter. J Lipid Res, 1999, 40(3):376–386
Ensler K, Mohammadieh M, Broijersen A, et al. Dexamethasone stimulates very low density lipoprotein (VLDL) receptor gene expression in differentiating 3T3-L1 cells. Biochim Biophys Acta, 2002, 1581(1–2):36–48
Wood JL, Russo AF. Autoregulation of cell-specific MAP kinase control of the tryptophan hydroxylase promoter. J Biol Chem, 2001, 276(24):21 262–21 271
Caivano M, Cohen P. Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. J Immunol, 2000, 164(6):3018–3025
Wang CB, Feng YM, Zong YQ, et al. Rapid isolation of large amount of plasma VLDL and LDL by a two step ultracentrifugation. J Tongji Med Univ, 1995, 15(4): 198–200
Qu S, Yang S, You Y, et al. Construction of eukaryotic expression vector pBLacZ and its expression both in vivo and in vitro. J Tongji Med Univ, 1996, 16(1):14–17
Suzuki J, Takahashi S, Oida K, et al. Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor. Biochem Biophys Res Commun, 1995, 206(3):835–842
Kosaka S, Takahashi S, Masamura K, et al. Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages. Circulation, 2001, 103(8): 1142–1147
Author information
Authors and Affiliations
Additional information
This project was supported by grant from National Natural Sciences Foundation of China (No. 39970307) and Hubei Provincial Natural Sciences Foundation of China (No. 2005ABA092).
Rights and permissions
About this article
Cite this article
Liu, Z., Li, H., Li, Y. et al. Up-regulation of VLDL receptor expression and its signaling pathway induced by VLDL and β-VLDL. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 1–7 (2009). https://doi.org/10.1007/s11596-009-0101-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-009-0101-9